{"id":"NCT03292458","sponsor":"Kristina Simonyan","briefTitle":"Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor","officialTitle":"Central Mechanisms and Treatment Response of Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2018-01-22","primaryCompletion":"2021-12-29","completion":"2024-10-11","firstPosted":"2017-09-25","resultsPosted":"2025-04-04","lastUpdate":"2025-04-04"},"enrollment":117,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"BASIC_SCIENCE"},"conditions":["Spasmodic Dysphonia","Voice Tremor"],"interventions":[{"type":"DRUG","name":"Sodium Oxybate","otherNames":["Placebo","Alcohol"]}],"arms":[{"label":"Clinical response to sodium oxybate","type":"EXPERIMENTAL"},{"label":"Central markers of clinical response","type":"EXPERIMENTAL"}],"summary":"Using a comprehensive approach of clinico-behavioral testing, neuroimaging and pharmacogenetics, the researchers will examine the clinical effects of sodium oxybate and the matched placebo on voice symptoms in spasmodic dysphonia and voice tremor.","primaryOutcome":{"measure":"Symptom Severity","timeFrame":"40 min after drug or placebo administration","effectByArm":[{"arm":"Alcohol-responsive (EtOH+) Laryngeal Dystonia","deltaMin":28,"sd":null},{"arm":"Alcohol-non-responsive (EtOH-) Laryngeal Dystonia","deltaMin":18.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.01"}]},"eligibility":{"minAge":"21 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["24386608","27808415","27346568","26843004","25929664","20194686"],"seeAlso":["https://reporter.nih.gov/search/dPfQ17fnGUOqdn2Teo9Xwg/project-details/10240318"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":50},"commonTop":["Mild Dizziness/ lightheadedness/unsteadiness/clumsiness","Mild Daytime sleepiness","Mild Headache","Mild Nausea","Mild Dry mouth"]}}